Clinical implications of heterogeneity of tumor response to radiation therapy
- 1 December 1992
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 25 (4) , 251-260
- https://doi.org/10.1016/0167-8140(92)90244-o
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Does Variation in thein VitroCellular Radiosensitivity Explain the Shallow Clinical Dose—control Curve for Malignant Melanoma?International Journal of Radiation Biology, 1990
- Breast and Other Cancers in Families with Ataxia-TelangiectasiaNew England Journal of Medicine, 1987
- The influence of hemoglobin level on the regression and long term local control of transitional cell carcinoma of the bladder following photon irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Re-evaluation ofin VitroRadiosensitivity of Human Fibroblasts of Different Genetic OriginsInternational Journal of Radiation Biology, 1986
- Radiation Biology of Malignant MelanomaActa Radiologica: Oncology, 1986
- The radioresponsiveness of human tumours and the initial slope ofthe cell survival curveRadiotherapy and Oncology, 1984
- Dosimetric Precision Requirements in Radiation TherapyActa Radiologica: Oncology, 1984
- Ataxia telangiectasia with cancer. An indication for reduced radiotherapy and chemotherapy dosesThe British Journal of Radiology, 1983
- Radiosensitivity in vitro of human fibroblasts derived from patients with a severe skin reaction to radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1980
- Radiosensitivity in ataxia-telangiectasiaThe British Journal of Radiology, 1975